BNP Paribas Financial Markets’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $998K | Buy |
|
|||||
|
2025
Q2 | $453K | Buy |
|
|||||
|
2025
Q1 | $351K | Sell |
|
|||||
|
2024
Q4 | $780K | Sell |
|
|||||
|
2024
Q3 | $1.07M | Buy |
|
|||||
|
2024
Q2 | $401K | Sell |
|
|||||
|
2024
Q1 | $2.15M | Sell |
|
|||||
|
2023
Q4 | $6.42M | Sell |
|
|||||
|
2023
Q3 | $9.04M | Buy |
|
|||||
|
2023
Q2 | $1.07M | Buy |
|
|||||
|
2023
Q1 | $944K | Buy |
|
|||||
|
2022
Q4 | $506K | Sell |
|
|||||
|
2022
Q3 | $893K | Buy |
|
|||||
|
2022
Q2 | $225K | Buy |
|
|||||
|
2022
Q1 | $86.1K | Sell |
|
|||||
|
2021
Q4 | $298K | Buy |
|
|||||
|
2021
Q3 | $144K | Buy |
|
|||||
|
2021
Q2 | $27.7K | Sell |
|
|||||
|
2021
Q1 | $55.6K | Sell |
|
|||||
|
2020
Q4 | $90.5K | Sell |
|
|||||
|
2020
Q3 | $103K | Buy |
|
|||||
|
2020
Q2 | $26.6K | Sell |
|
|||||
|
2020
Q1 | $50.7K | Buy |
|
|||||
|
2019
Q4 | $40.7K | Buy |
|
|||||
|
2019
Q3 | $23.6K | Buy |
|
|||||
|
2019
Q2 | $25.6K | Sell |
|
|||||
|
2019
Q1 | $42.1K | Buy |
|